Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine and Isoniazid for LTBI in Taiwan
NCT02208427Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifapentine in latent tuberculosis infection (LTBI), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
rifapentine
03
Conditions
latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on NCT02208427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02208427.